NCT07158463 Experience With Therapeutic Plasma Exchange in the Pediatric Nephrology Unit of Sohag University Hospital
| NCT ID | NCT07158463 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sohag University |
| Condition | Experience With Therapeutic Plasma Exchange in the Pediatric Nephrology Unit |
| Study Type | OBSERVATIONAL |
| Enrollment | 25 participants |
| Start Date | 2025-08-15 |
| Primary Completion | 2026-08-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 25 participants in total. It began in 2025-08-15 with a primary completion date of 2026-08-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Plasmapheresis also known as a therapeutic plasma exchange (TPE) TPE is an extracorporeal blood purification technique designed for the removal of large-molecular-weight substances. Examples of these substances include pathogenic autoantibodies, immune complexes, cryoglobulins, myeloma light chains, endotoxin, and cholesterol-containing lipoproteins Document the indications, procedures, outcomes, and complications associated with TPE in pediatric patients at Sohag University Hospital. To compare our findings with existing national and international data to identify areas for improvement and standardization. To evaluate the safety and efficacy of TPE in our pediatric nephrology unit.
Eligibility Criteria
Inclusion Criteria: All pediatric patients (aged 1-18 years) who underwent TPE during the study period. Both male and female. Exclusion Criteria: Patients who cannot tolerate central line placement Patients who are in an actively septic state or are hemodynamically unstable . Patients who have allergies to fresh frozen plasma (FFP) or albumin, depending on the type of plasma exchange
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07158463 clinical trial?
This trial is open to participants of all sexes, aged 1 Year or older, up to 18 Years, studying Experience With Therapeutic Plasma Exchange in the Pediatric Nephrology Unit. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07158463 currently recruiting?
Yes, NCT07158463 is actively recruiting participants. Contact the research team at shohandaahmed12345@gmail.com for enrollment information.
Where is the NCT07158463 trial being conducted?
This trial is being conducted at Sohag, Egypt.
Who is sponsoring the NCT07158463 clinical trial?
NCT07158463 is sponsored by Sohag University. The trial plans to enroll 25 participants.